54.92
0.40%
+0.22
Corteva Inc stock is currently priced at $54.92, with a 24-hour trading volume of 2.29M.
It has seen a +0.40% increased in the last 24 hours and a -2.45% declined in the past month.
The chart indicates a potential bullish trend, as the stock is above the $54.57 pivot point. If it approaches the $55.08 resistance level, significant changes may occur.
Previous Close:
$54.70
Open:
$54.37
24h Volume:
2.29M
Market Cap:
$38.38B
Revenue:
$17.23B
Net Income/Loss:
$735.00M
P/E Ratio:
42.57
EPS:
1.29
Net Cash Flow:
$1.17B
1W Performance:
+0.22%
1M Performance:
-2.45%
6M Performance:
+12.75%
1Y Performance:
-7.91%
Corteva Inc Stock (CTVA) Company Profile
Name
Corteva Inc
Sector
Industry
Phone
302-774-1000
Address
974 Centre Road, Wilmington, DE
Corteva Inc Stock (CTVA) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Feb-12-24 | Upgrade | Loop Capital | Hold → Buy |
Feb-02-24 | Upgrade | Exane BNP Paribas | Underperform → Neutral |
Nov-27-23 | Downgrade | Berenberg | Buy → Hold |
Nov-14-23 | Downgrade | Barclays | Overweight → Equal Weight |
Oct-20-23 | Upgrade | Oppenheimer | Perform → Outperform |
Sep-05-23 | Upgrade | UBS | Neutral → Buy |
Jul-25-23 | Downgrade | Redburn | Buy → Neutral |
Jun-28-23 | Initiated | Canaccord Genuity | Buy |
May-22-23 | Upgrade | Vertical Research | Hold → Buy |
Apr-06-23 | Initiated | Oppenheimer | Perform |
Jan-19-23 | Initiated | Wells Fargo | Overweight |
Jan-11-23 | Upgrade | BofA Securities | Underperform → Neutral |
Nov-16-22 | Downgrade | UBS | Buy → Neutral |
Nov-15-22 | Downgrade | Loop Capital | Buy → Hold |
Aug-08-22 | Upgrade | JP Morgan | Neutral → Overweight |
Aug-08-22 | Upgrade | ROTH Capital | Neutral → Buy |
Jul-14-22 | Initiated | Credit Suisse | Outperform |
Jun-01-22 | Initiated | Barclays | Overweight |
May-06-22 | Downgrade | JP Morgan | Overweight → Neutral |
Apr-14-22 | Upgrade | Loop Capital | Hold → Buy |
Apr-14-22 | Downgrade | Vertical Research | Buy → Hold |
Jan-31-22 | Upgrade | Redburn | Neutral → Buy |
Oct-18-21 | Downgrade | Loop Capital | Buy → Hold |
Oct-13-21 | Initiated | Mizuho | Buy |
Oct-08-21 | Initiated | ROTH Capital | Buy |
Sep-01-21 | Initiated | Berenberg | Buy |
Aug-09-21 | Upgrade | Monness Crespi & Hardt | Sell → Neutral |
May-10-21 | Downgrade | BofA Securities | Buy → Underperform |
Apr-19-21 | Upgrade | Loop Capital | Hold → Buy |
Feb-05-21 | Upgrade | JP Morgan | Neutral → Overweight |
Feb-05-21 | Reiterated | Monness Crespi & Hardt | Sell |
Dec-18-20 | Downgrade | Susquehanna | Positive → Neutral |
Dec-14-20 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
Nov-10-20 | Upgrade | Argus | Hold → Buy |
Oct-19-20 | Upgrade | BofA Securities | Neutral → Buy |
Oct-19-20 | Downgrade | Exane BNP Paribas | Outperform → Underperform |
Aug-11-20 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
Aug-10-20 | Downgrade | BofA Securities | Buy → Neutral |
Jul-13-20 | Upgrade | BofA Securities | Underperform → Buy |
Jun-26-20 | Initiated | Cleveland Research | Neutral |
Jun-16-20 | Upgrade | Vertical Research | Hold → Buy |
Jun-08-20 | Downgrade | Monness Crespi & Hardt | Neutral → Sell |
May-11-20 | Downgrade | BofA/Merrill | Neutral → Underperform |
Apr-17-20 | Downgrade | BofA/Merrill | Buy → Neutral |
Apr-17-20 | Upgrade | Loop Capital | Sell → Hold |
Apr-01-20 | Upgrade | Exane BNP Paribas | Neutral → Outperform |
Mar-31-20 | Upgrade | Susquehanna | Neutral → Positive |
Mar-26-20 | Initiated | KeyBanc Capital Markets | Sector Weight |
Mar-19-20 | Upgrade | Edward Jones | Hold → Buy |
Mar-13-20 | Upgrade | BofA/Merrill | Neutral → Buy |
Mar-10-20 | Upgrade | Monness Crespi & Hardt | Sell → Neutral |
View All
Corteva Inc Stock (CTVA) Latest News
Insights Into Corteva, Inc. (CTVA) Q1: Wall Street Projections for Key Metrics
Zacks Investment Research
Corteva, Inc. (CTVA) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Zacks Investment Research
Analyst Expectations For Corteva's Future
Benzinga
Wall Street Bulls Look Optimistic About Corteva, Inc. (CTVA): Should You Buy?
Zacks Investment Research
U.S. Wide-Moat Stocks On Sale - The March 2024 Heat Map
Seeking Alpha
Cibus (CBUS) Moves 6.7% Higher: Will This Strength Last?
Zacks Investment Research
Corteva Inc Stock (CTVA) Financials Data
Corteva Inc (CTVA) Revenue 2024
CTVA reported a revenue (TTM) of $17.23 billion for the quarter ending December 31, 2023, a -1.31% decline year-over-year.
Corteva Inc (CTVA) Net Income 2024
CTVA net income (TTM) was $735.00 million for the quarter ending December 31, 2023, a -35.92% decrease year-over-year.
Corteva Inc (CTVA) Cash Flow 2024
CTVA recorded a free cash flow (TTM) of $1.17 billion for the quarter ending December 31, 2023, a +339.70% increase year-over-year.
Corteva Inc (CTVA) Earnings per Share 2024
CTVA earnings per share (TTM) was $1.02 for the quarter ending December 31, 2023, a -35.03% decline year-over-year.
Corteva Inc Stock (CTVA) Insider Trading
Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
---|---|---|---|---|---|---|---|
Eathington Samuel R | See Remarks |
Nov 28 '23 |
Buy |
46.07 |
1,094 |
50,401 |
41,066 |
GLENN TIMOTHY P | EVP, Seed Business Unit |
Nov 14 '23 |
Buy |
45.99 |
4,000 |
183,944 |
163,121 |
King Robert D. | EVP, Crop Protection Business |
Nov 14 '23 |
Buy |
46.77 |
640 |
29,933 |
59,701 |
FUERER CORNEL B | SVP, Gen Counsel and Secretary |
Nov 13 '23 |
Buy |
43.41 |
350 |
15,193 |
108,006 |
ANDERSON DAVID J | EVP, Chief Financial Officer |
Sep 15 '23 |
Buy |
52.97 |
2,000 |
105,940 |
65,308 |
About Corteva Inc
Corteva, Inc. provides agriculture products worldwide. The company develops and supplies germplasm and traits in corn, soybean, and sunflower seed markets. It also supplies products to the agricultural input industry that protect against weeds, insects and other pests, and diseases, as well as to enhance crop health. The company is based in Wilmington, Delaware. Corteva, Inc. operates independently of DowDuPont Inc. as of June 1, 2019.
Cap:
|
Volume (24h):